Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). - Wikidata - awgldk - TriplyDB

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

http://www.wikidata.org/entity/Q52576052

about

Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum.Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells.High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology Intestinal permeability and its relevance for absorption and elimination.Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.Colonic treatments and targets: issues and opportunities.Altered functions and expressions of drug transporters in liver, kidney and intestine in disorders of local and remote organs: possible role of oxidative stress in the pathogenesis.Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention.Drug transporter pharmacogenetics in nucleoside-based therapies.Intestinal inflammation and the enterocyte transportome.Impeded protein folding and function in active inflammatory bowel disease.Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.The impact of drug transporters on adverse drug reaction.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.Clinical determinants of calcineurin inhibitor disposition: a mechanistic review.Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study.CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity.Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats.P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.Effect of proinflammatory cytokine IL-6 on efflux transport of rebamipide in Caco-2 cells.High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis.Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators.Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein.Drug transport into the central nervous system: using newer findings about the blood-brain barriers.Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis.Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis.Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.Transporters MRP1 and MRP2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung Infection.Decreased Serum Bilirubin Levels and Increased Uric Acid Levels are Associated with Ulcerative Colitis

P2860

Q28081272-199EAAFF-B0A1-4D84-A153-BA74585CF500 Q33579831-5AF5AD80-176D-40A0-909E-70C20CB2B54B Q34557503-D6A68D20-7C18-44DC-A053-D8938FD41FDE Q35202603-F9991233-DF45-45CD-96F8-6FE0FE5B23EA Q36245600-50786041-32BC-4EFD-9E40-E08B68E66E2D Q36985043-917DD802-DF22-4E45-A72F-D5462F90F3D4 Q37207759-61E09FAB-D9B0-40EB-ACC2-5BF61CA6EE9B Q37530912-F2BB8C94-C54F-4469-9693-DBB13F2F25DD Q37556541-5E8363FB-89BD-4CDD-A59D-C01CA8A0BE59 Q37621335-37D5D5C1-62FE-4CA4-8900-46E803AD332B Q37760954-24F8A261-C7E6-4242-85D1-081FED117A7E Q37905164-6E358233-E114-49DB-B1EB-0A15437B9427 Q37905168-0B90837D-8D01-4B60-B29E-2F95A8D51CA3 Q37964754-EAEE5911-6ED4-48D1-B0B1-76C999EBA3A0 Q38038547-ACC06AB5-0687-4240-A2B4-D41B22F6F1B0 Q38075820-8DA5D133-0AD2-49EB-8824-74FB87FF645A Q38266172-4ADC2726-0AE8-4F99-92CB-F76DB1B9B202 Q38390695-477E23DE-58E5-4B7D-9A9F-E1A63E45A37E Q38748975-80D42AF2-CA2E-4493-8319-0807B6E101E2 Q38814448-3436889F-2172-4F14-9F4E-422A85DC1F74 Q38903289-CAF3A417-1217-4CD7-A496-68AC820304E3 Q39767486-CEDB35CC-7030-4F9F-8B8D-01956AA117F6 Q40755393-F1632138-1EEE-426B-A2AB-EFBE9DE90976 Q42317765-F702FFF4-5B23-420F-A893-67F8BDB6F1BF Q42498104-EDFA75E0-7D2B-4764-A740-B8408845D186 Q43284329-390B801E-7484-4C8F-AB3A-F9B6CFB38FB0 Q43532813-D785F620-AA5F-4647-987D-6CD92B99029E Q48100284-64DDCE2A-D018-4120-8953-68EC0E837FBB Q48489678-B8BDF523-8EEE-47F4-BE2E-33A481D4899B Q53483201-B8613871-99C7-4F01-95C2-57002FE0A4FD Q53539411-578A51F4-EFD8-4CAD-A0C3-23CBAD849F56 Q54332728-3E0FA04A-B439-4DB6-A08B-98E90C05E599 Q55562726-AA5177E3-00D4-4E2D-844E-54FF1399739F Q58757224-10B53BCA-512C-41DC-95A6-164FF70B0CB4

P2860

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

http://www.wikidata.org/entity/Q52576052

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Efflux transporters in ulcerat ...... BCRP (ABCG2) and Pgp (ABCB1).

@en

Efflux transporters in ulcerative colitis: decreased expression of BCRP

@nl

type

label

Efflux transporters in ulcerat ...... BCRP (ABCG2) and Pgp (ABCB1).

@en

Efflux transporters in ulcerative colitis: decreased expression of BCRP

@nl

prefLabel

Efflux transporters in ulcerat ...... BCRP (ABCG2) and Pgp (ABCB1).

@en

Efflux transporters in ulcerative colitis: decreased expression of BCRP

@nl

P1433

Q52576052-18CE5708-6EB1-4C35-8391-C2556460DE06

P1476

Q52576052-4C3917D9-D470-487F-8D05-439F0CDD928E

P2093

Q52576052-17E44E14-1E83-4C45-B637-24CF7F68A918

Q52576052-6160FAE0-4E19-4AC6-9B89-5D9F426CAD5C

Q52576052-6BE153B4-2048-4FC6-A23F-6D5D9A37DD45

Q52576052-BB1D30F2-E66E-4D4E-96FE-9A07775C2EA8

Q52576052-C4E2A3EC-A2EA-4617-AC82-C00DBED5DD58

Q52576052-D70D76A4-9D84-49A8-8363-4D4E964EB8DF

P2860

Q52576052-001E89D3-AC10-4EC5-89F7-F74DA55F1665

Q52576052-073440C1-A3DD-41F7-B1EB-4D03C7D65745

Q52576052-0AC5E187-FCFD-4C7B-AC55-006E5A9A7046

Q52576052-0C53FB2E-9F21-4E45-9B99-D9C870859888

Q52576052-0EB3AF20-CD87-4402-9107-98D195BB0705

Q52576052-21872341-CE1F-4D47-9D38-0F0325C19F42

Q52576052-2F4F21D6-04C1-47DD-9DFE-7D02141A6BA9

Q52576052-3C9A5A3F-7586-4719-98E3-EB7C838D2DD8

Q52576052-4FBC02FC-B271-4D9D-9F68-EA9952CFA3E9

Q52576052-57B3D3FD-167C-4EFF-ACD3-104098B89941

P304

Q52576052-6956F986-B5B7-4AE7-A9B8-984179D1997C

P31

Q52576052-E5521137-F544-43FE-8A1D-405E05273667

P356

Q52576052-57230544-EC48-452F-8699-FE7E4041154B

P433

Q52576052-1D29F5F1-E741-45ED-BC08-E523F407B29C

P478

Q52576052-9E86E452-05FF-4D6C-8D9E-BA23E0E8616B

P577

Q52576052-DD6B3CA2-7D79-4B04-8C7B-08BF973C7579

P5875

Q52576052-93865947-DBC9-45F8-BA24-308D82B83D4C

P698

Q52576052-07F69A25-8231-4B51-84C8-309B79D6BDA0

P356

P1433

Inflammatory Bowel Diseases

P1476

Efflux transporters in ulcerat ...... BCRP (ABCG2) and Pgp (ABCB1).

@en

P2093

Anders Rönnblom

http://www.w3.org/2001/XMLSchema#string

Andreas Kindmark

http://www.w3.org/2001/XMLSchema#string

Annica Jacobson

http://www.w3.org/2001/XMLSchema#string

Fredrik Rorsman

http://www.w3.org/2001/XMLSchema#string

Gunilla Englund

http://www.w3.org/2001/XMLSchema#string

Per Artursson

http://www.w3.org/2001/XMLSchema#string

P2860

Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha

Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A

Role of transport proteins in drug absorption, distribution and excretion.

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Chemoprevention of colorectal cancer in ulcerative colitis.

ABC of oral bioavailability: transporters as gatekeepers in the gut.

Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen

From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation.

P304

291-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.20030

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6593919

http://www.w3.org/2001/XMLSchema#string

P698

17206689

http://www.w3.org/2001/XMLSchema#string